Results

Total Results: 3,151 records

Showing results for "disease".

381. Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular Events (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/polyunsaturated-fatty-protocol.pdf
     January 01, 2024 - participants ● Participants who are pre- or post-bariatric surgery ● Participants with other chronic diseases … (e.g., cancer, gastrointestinal disease, rheumatic disease, chronic kidney disease, neurologic diseases … (e.g., history of myocardial infarction, angina, stroke, arrhythmia), including congenital heart diseases … Substitution of Dairy Products and Risk of Death and Cardiometabolic Diseases: A Systematic Review and … Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.

382. Dietary Saturated Fat Replacement and Plasma Lipid and Cardiovascular Events (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/saturated-fat-replacement-protocol.pdf
     January 01, 2024 - participants ● Participants who are pre- or post-bariatric surgery ● Participants with other chronic diseases … (e.g., cancer, gastrointestinal disease, rheumatic disease, chronic kidney disease, neurologic diseases … (e.g., history of myocardial infarction, angina, stroke, arrhythmia), including congenital heart diseases … Red meat intake and risk of coronary heart disease among US men: prospective cohort study. … Substitution of Dairy Products and Risk of Death and Cardiometabolic Diseases: A Systematic Review and

383. Executive Summary_Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
     August 01, 2024 - doublet chemoradiation (CRT) with 5-fluorouracil (5FU) plus mitomycin (MMC) likely results in greater disease-free … • Compared with concurrent CRT with 5FU, CRT with 5FU plus MMC may result in greater disease-free … with capecitabine plus MMC, CRT with paclitaxel plus capecitabine plus MMC showed greater overall, disease … Moderate Disease-specific mortality (up to 5 yrs) 1; RCT; n=585 CRT favored over RT alone; rate … Low Disease-free survival (up to 3 yrs) 1; RCT; n=144 Significantly greater in the paclitaxel arm

384. Restless-Legs Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
     December 16, 2011 - and Objectives for the Systematic Review Overview Restless legs syndrome (RLS) or Willis-Ekbom disease … If the disease progresses, symptoms may occur earlier in the day and intensify even further at night … used to assess disease severity and treatment- induced changes in disease status. … Yet, the disease is chronic, often requiring life-long treatment. … and definition of clinically significant change in disease status used in individual studies.

385. CER 244 Evidence Summary: Safety of Vaccines Used for Routine Immunization in the United States: An Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
     May 01, 2021 - vaccines are effective in controlling the spread of and even eradicating a variety of infectious diseases … The list of vaccines is based on the Centers for Disease Control and Prevention’s (CDC) recommended … , autoimmune thyroiditis (Hashimoto’s disease) Note: No evidence of increased risk indicates that … Centers for Disease Control and Prevention. Immunization Schedules: Table 1. … Centers for Disease Control and Prevention. Immunization Schedules: Table 1.

386. Dyspnea DEcIDE (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dyspnea_research.pdf
     April 01, 2010 - requires valid, reliable, and responsive measures of the care provided to patients across settings and diseases … review of over 5000 titles in Western literature for quality measures of symptom management across diseases … care measure set.17 The dyspnea measure evaluates the proportion of patients with advanced chronic diseases … VAS were felt by panelists to be appropriate for clinical dyspnea assessment in chronic progressive diseases … Descriptors of breathlessness in cardiorespiratory diseases.

387. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
     March 09, 2010 - arthritis (JIA), formerly known as juvenile rheumatoid arthritis, is the most common rheumatologic disease … with more destructive joint disease … Evaluating changes in JIA disease status can be challenging. … First, these measures evaluate relative and not absolute changes in disease progression. … Effects of Omega-3 Fatty Acids on Cardiovascular Disease.

388. Effectiveness of Practice-based Interventions Addressing Concomitant Mental Health and Chronic Medical Conditions in the Primary Care Setting | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/depression-chronic-conditions-interventions/research-protocol
     December 01, 2019 - pulmonary disease. 16 Among primary care outpatients with hypertension, diabetes, and/or heart disease … In 2010, cardiovascular, lung, and blood diseases were projected to cost $486 billion in health care … mortality Disease-related morbidity Disease-related functional status Mental health-related quality … mortality Disease-related morbidity Disease-related functional status General health-related quality … Morbidity & mortality: 2009 chart book on cardiovascular, lung, and blood diseases.

389. Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/survival-quality/research
     November 01, 2017 - Progression-free survival (PFS), defined as the time from random assignment in a clinical trial to disease … range of potential biases, and its use as a surrogate for OS has been demonstrated only for certain disease … KQ2 sought to determine an association between PFS and QOL or related outcomes, such as disease symptoms … The four studies demonstrated better QOL or disease symptoms among patients who remained progression-free … compared with those who had disease progression.

390. Draft Comparative Effectiveness Review Appendicies (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes.pdf
     April 01, 2005 - Imaging test: Laboratory test: Clinical exam test: Demographics: Concurrent diseases … Survival in renal vascular disease. … Surgery for renovascular diseases: a single-center experience in revascularizing renal artery stenosis … HTN and CKD • Populations had ≥60% to ≥80% stenosis • Populations had unilateral and bilateral diseases … that bilateral versus unilateral disease did not predict progressive kidney disease

391. Effective Health Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
     January 01, 2010 - events (e.g., ischemic stroke, symptomatic peripheral arterial disease), or (3) undergoing percutaneous … s): (1) Patients with acute coronary syndrome, (2) patients who have suffered other cardiovascular disease-related … events (e.g., ischemic stroke, symptomatic peripheral arterial disease), or (3) patients undergoing … Outcome(s): Recurrent ischemic events, stent thromboses, cardiovascular disease- related morbidity and …  While clopidogrel may decrease morbidity and mortality associated with several cardiovascular diseases

392. Anemia | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/anemia
     October 12, 2012 - 2012 Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease … Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage Renal Disease … August 29, 2011 Laboratory Biomarkers for Iron Deficiency Anemia in Late Stage Chronic Kidney Disease … March 31, 2011 Comparative Effectiveness Research to Improve Anemia Management and Cardiovascular Disease … Outcomes in End-Stage Renal Disease (ESRD) Systematic Review Archived May 23, 2006

393. Diagnostic Errors in the Emergency Department: A Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diagnostic-errors-emergency/research
     February 01, 2023 - Variation in diagnostic error rates by disease are striking (range 1.5% for myocardial infarction to … Stroke, the top serious harm-producing disease, is missed an estimated 17% of the time. … ), well below the estimated average rate across all diseases (5.7%). … For a given disease, nonspecific or atypical symptoms increase the likelihood of error. … While most disease-specific error rates derived from mainly U.S.

394. Arthritis-Psoriatric Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
     April 01, 2012 - The condition is associated with the skin disease psoriasis, but not all people with psoriasis will … Additionally, PsA may predate the development of skin disease, leading to some diagnostic uncertainty … Available therapies for PsA include corticosteroids, oral disease-modifying antirheumatic drugs or … Analytic framework for treatment for psoriatic arthritis DMARDS = disease-modifying antirheumatic … * American College of Rheumatology measure of disease activity: response scores based on 20, 50, or

395. Appendix K Rapid Evidence Review Treatments for Clostridium difficile Colitis (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/clinical-pathway-methods-report-appendix-k.pdf
     February 01, 2018 - Australasian Society of Infectious Diseases 20164 Oral antibiotic treatment – nonsevere disease … ; FMT: Fecal microbiota transplantation; ID: infectious disease; SHEA/IDSA: Infectious Diseases Society … Debast SB, Bauer MP, Kuijper EJ, Committee Centre for Infectious Diseases. … Definitions of Disease Severity by Guideline Organization Definitions Infectious Diseases Society of … Australasian Society of Infectious Diseases 20164 CDI: A + (B or C) A.

396. Pain | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/pain?page=2
     August 23, 2012 - Systematic Review Archived August 17, 2012 Treatment Strategies for Women With Coronary Artery Disease … Review Archived June 12, 2012 Noninvasive Technologies for the Diagnosis of Coronary Artery Disease … January 24, 2011 Comparative Effectiveness of Treatment Strategies for Women With Coronary Artery Disease … 2010 Comparative Effectiveness of Noninvasive Technologies for the Diagnosis of Coronary Artery Disease … Comparison of Percutaneous Coronary Interventions With Bypass Graft Surgery in Nonacute Coronary Artery Disease

397. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
     May 07, 2010 - extensively for treatment of hypertension, heart failure, myocardial infarction, diabetes, and renal disease … disease or events, symptomatic coronary artery disease, end-stage renal disease, quality of life, … , and cerebrovascular disease- specific) o Morbidity (cardiac events [MI], heart failure, cerebral … vascular disease or events [including stroke], symptomatic coronary artery disease, end-stage renal … disease, peripheral vascular disease [as clinically manifest, not markers of], quality of life)

398. Diagnostic Errors in the Emergency Department: A Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diagnostic-errors-emergency-updated/research
     August 01, 2023 - Variation in diagnostic error rates by disease are striking (range 1.5% for myocardial infarction to … Stroke, the top serious harm-producing disease, is missed an estimated 17% of the time. … ), well below the estimated average rate across all diseases (5.7%). … For a given disease, nonspecific or atypical symptoms increase the likelihood of error. … While most disease-specific error rates derived from mainly U.S.

399. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
     January 01, 2007 - extensively for treatment of hypertension, heart failure, myocardial infarction, diabetes, and renal disease … disease-specific mortality) and morbidity (cardiac events [myocardial infarction], heart failure, cerebral … vascular disease or events [including stroke], symptomatic coronary artery disease, end stage renal … disease, peripheral vascular disease, and quality of life). 4Safety outcomes considered were overall … (either based on creatinine, GFR, or renal disease) proteinuria).

400. Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/musculoskeletal-complaints-tests-children/research
     December 01, 2019 - The 12 case-control studies that examined other test-disease combinations did not specifically address … review was not applicable to the population of interest as most studies examined children with known disease … a clinical assessment that suggests the presence of an inflammatory arthritis or connective tissue disease … Research Protocol Dec 20, 2024 The Performance of Fusion Procedures for Degenerative Disease … in Cardiothoracic Surgery Systematic Review Nov 14, 2023 Cervical Degenerative Disease